S&P 500   4,217.75 (+0.91%)
DOW   33,103.62 (+0.59%)
QQQ   351.63 (+1.05%)
AAPL   179.80 (+1.44%)
MSFT   331.20 (+0.86%)
META   270.89 (+2.33%)
GOOGL   123.23 (+0.29%)
AMZN   122.90 (+1.92%)
TSLA   206.54 (+1.28%)
NVDA   393.99 (+4.14%)
NIO   7.59 (+0.80%)
BABA   82.99 (+4.32%)
AMD   120.05 (+1.56%)
T   15.83 (+0.64%)
F   12.07 (+0.58%)
MU   69.09 (+1.30%)
CGC   0.84 (+0.72%)
GE   104.79 (+3.21%)
DIS   88.70 (+0.84%)
AMC   4.61 (+2.44%)
PFE   38.08 (+0.16%)
PYPL   63.19 (+1.94%)
NFLX   404.56 (+2.36%)
S&P 500   4,217.75 (+0.91%)
DOW   33,103.62 (+0.59%)
QQQ   351.63 (+1.05%)
AAPL   179.80 (+1.44%)
MSFT   331.20 (+0.86%)
META   270.89 (+2.33%)
GOOGL   123.23 (+0.29%)
AMZN   122.90 (+1.92%)
TSLA   206.54 (+1.28%)
NVDA   393.99 (+4.14%)
NIO   7.59 (+0.80%)
BABA   82.99 (+4.32%)
AMD   120.05 (+1.56%)
T   15.83 (+0.64%)
F   12.07 (+0.58%)
MU   69.09 (+1.30%)
CGC   0.84 (+0.72%)
GE   104.79 (+3.21%)
DIS   88.70 (+0.84%)
AMC   4.61 (+2.44%)
PFE   38.08 (+0.16%)
PYPL   63.19 (+1.94%)
NFLX   404.56 (+2.36%)
S&P 500   4,217.75 (+0.91%)
DOW   33,103.62 (+0.59%)
QQQ   351.63 (+1.05%)
AAPL   179.80 (+1.44%)
MSFT   331.20 (+0.86%)
META   270.89 (+2.33%)
GOOGL   123.23 (+0.29%)
AMZN   122.90 (+1.92%)
TSLA   206.54 (+1.28%)
NVDA   393.99 (+4.14%)
NIO   7.59 (+0.80%)
BABA   82.99 (+4.32%)
AMD   120.05 (+1.56%)
T   15.83 (+0.64%)
F   12.07 (+0.58%)
MU   69.09 (+1.30%)
CGC   0.84 (+0.72%)
GE   104.79 (+3.21%)
DIS   88.70 (+0.84%)
AMC   4.61 (+2.44%)
PFE   38.08 (+0.16%)
PYPL   63.19 (+1.94%)
NFLX   404.56 (+2.36%)
S&P 500   4,217.75 (+0.91%)
DOW   33,103.62 (+0.59%)
QQQ   351.63 (+1.05%)
AAPL   179.80 (+1.44%)
MSFT   331.20 (+0.86%)
META   270.89 (+2.33%)
GOOGL   123.23 (+0.29%)
AMZN   122.90 (+1.92%)
TSLA   206.54 (+1.28%)
NVDA   393.99 (+4.14%)
NIO   7.59 (+0.80%)
BABA   82.99 (+4.32%)
AMD   120.05 (+1.56%)
T   15.83 (+0.64%)
F   12.07 (+0.58%)
MU   69.09 (+1.30%)
CGC   0.84 (+0.72%)
GE   104.79 (+3.21%)
DIS   88.70 (+0.84%)
AMC   4.61 (+2.44%)
PFE   38.08 (+0.16%)
PYPL   63.19 (+1.94%)
NFLX   404.56 (+2.36%)
NASDAQ:IRTC

iRhythm Technologies (IRTC) Stock Forecast, Price & News

$113.06
-1.21 (-1.06%)
(As of 12:34 PM ET)
Compare
Today's Range
$111.65
$114.75
50-Day Range
$114.27
$139.70
52-Week Range
$85.74
$164.69
Volume
87,769 shs
Average Volume
319,985 shs
Market Capitalization
$3.44 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$154.40

iRhythm Technologies MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.80 Rating Score
Upside/​Downside
35.1% Upside
$154.40 Price Target
Short Interest
Bearish
7.38% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.07mentions of iRhythm Technologies in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$987,677 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($3.11) to ($2.22) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.91 out of 5 stars

Medical Sector

1377th out of 1,980 stocks

Surgical & Medical Instruments Industry

139th out of 200 stocks


IRTC stock logo

About iRhythm Technologies (NASDAQ:IRTC) Stock

iRhythm Technologies, Inc. is a digital healthcare company, which engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services. It also provides solutions that detect, predict, and prevent disease. The company was founded by Uday N. Kumar in September 2006 and is headquartered in San Francisco, CA.

Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

IRTC Stock News Headlines

AI is Unstoppable. Now Is The Time!
AI, or Artificial Intelligence, is all the rage right now. AI technologies are empowering users in every industry to increase sales, efficiency, and productivity. It's truly a case of adapt or fail.
Highly Profitable Restaurant Brand Expands to Canada
Invest in the Canadian Expansion with Debut: The Exclusive Franchisee with Proven Success.
8-K: iRhythm Technologies, Inc.
What 9 Analyst Ratings Have To Say About iRhythm Technologies
BTIG Sticks to Its Buy Rating for Irhythm Technologies (IRTC)
See More Headlines

IRTC Price History

IRTC Company Calendar

Last Earnings
5/04/2023
Today
6/01/2023
Next Earnings (Estimated)
8/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:IRTC
Fax
N/A
Employees
1,793
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$154.40
High Stock Price Forecast
$190.00
Low Stock Price Forecast
$130.00
Forecasted Upside/Downside
+35.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.80
Research Coverage
10 Analysts

Profitability

Net Income
$-116,150,000.00
Pretax Margin
-24.27%

Debt

Sales & Book Value

Annual Sales
$410.92 million
Book Value
$7.28 per share

Miscellaneous

Free Float
30,340,000
Market Cap
$3.47 billion
Optionable
Optionable
Beta
1.41

Key Executives

  • Quentin S. Blackford
    President, Chief Executive Officer & Director
  • Brice Bobzien
    Chief Financial Officer
  • Mark J. DayMark J. Day
    Chief Technology Officer
  • Mintu Turakhia
    Chief Medical & Scientific Officer
  • Reyna M. Fernandez
    Chief Human Resources Officer & Executive VP













IRTC Stock - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 2 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price forecast for 2023?

10 analysts have issued 12-month price objectives for iRhythm Technologies' stock. Their IRTC share price forecasts range from $130.00 to $190.00. On average, they predict the company's stock price to reach $154.40 in the next twelve months. This suggests a possible upside of 35.7% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2023?

iRhythm Technologies' stock was trading at $93.67 at the beginning of 2023. Since then, IRTC shares have increased by 21.5% and is now trading at $113.77.
View the best growth stocks for 2023 here
.

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our IRTC earnings forecast
.

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) posted its quarterly earnings data on Thursday, May, 4th. The company reported ($1.29) EPS for the quarter, missing the consensus estimate of ($0.80) by $0.49. The firm had revenue of $111.44 million for the quarter, compared to the consensus estimate of $107.57 million. iRhythm Technologies had a negative net margin of 24.34% and a negative trailing twelve-month return on equity of 43.22%.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies updated its FY 2023 earnings guidance on Friday, April, 14th. The company provided EPS guidance of for the period. The company issued revenue guidance of $475.00 million-$485.00 million, compared to the consensus revenue estimate of $482.18 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Glassdoor.com. Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

(IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

What is iRhythm Technologies' stock symbol?

iRhythm Technologies trades on the NASDAQ under the ticker symbol "IRTC."

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by many different retail and institutional investors. Top institutional shareholders include Sands Capital Management LLC (7.94%), BlackRock Inc. (7.45%), FMR LLC (7.39%), Artisan Partners Limited Partnership (4.51%), Mackenzie Financial Corp (4.06%) and Blair William & Co. IL (3.31%). Insiders that own company stock include Daniel G Wilson, David A Vort, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy, Quentin S Blackford and Raymond W Scott.
View institutional ownership trends
.

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iRhythm Technologies' stock price today?

One share of IRTC stock can currently be purchased for approximately $113.77.

How much money does iRhythm Technologies make?

iRhythm Technologies (NASDAQ:IRTC) has a market capitalization of $3.47 billion and generates $410.92 million in revenue each year. The company earns $-116,150,000.00 in net income (profit) each year or ($3.47) on an earnings per share basis.

How many employees does iRhythm Technologies have?

The company employs 1,793 workers across the globe.

How can I contact iRhythm Technologies?

iRhythm Technologies' mailing address is 650 TOWNSEND STREET SUITE 500, San Francisco CA, 94103. The official website for the company is www.irhythmtech.com. The company can be reached via phone at (415) 632-5700 or via email at investors@irhythmtech.com.

This page (NASDAQ:IRTC) was last updated on 6/1/2023 by MarketBeat.com Staff

My Account -